Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and initial validation of composite parent- and child-centered disease assessment indices for juvenile idiopathic arthritis.
Consolaro A, Ruperto N, Pistorio A, Lattanzi B, Solari N, Galasso R, Pederzoli S, Varnier GC, Dolezalova P, Alessio M, Burgos-Vargas R, Vesely R, Martini A, Ravelli A; Paediatric Rheumatology International Trials Organisation. Consolaro A, et al. Among authors: varnier gc. Arthritis Care Res (Hoboken). 2011 Sep;63(9):1262-70. doi: 10.1002/acr.20509. Arthritis Care Res (Hoboken). 2011. PMID: 21618454 Free article.
Evaluation of 21-numbered circle and 10-centimeter horizontal line visual analog scales for physician and parent subjective ratings in juvenile idiopathic arthritis.
Filocamo G, Davì S, Pistorio A, Bertamino M, Ruperto N, Lattanzi B, Consolaro A, Magni-Manzoni S, Galasso R, Varnier GC, Martini A, Ravelli A. Filocamo G, et al. Among authors: varnier gc. J Rheumatol. 2010 Jul;37(7):1534-41. doi: 10.3899/jrheum.091474. Epub 2010 Jun 15. J Rheumatol. 2010. PMID: 20551105
Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis.
Ravelli A, Varnier GC, Oliveira S, Castell E, Arguedas O, Magnani A, Pistorio A, Ruperto N, Magni-Manzoni S, Galasso R, Lattanzi B, Dalprà S, Battagliese A, Verazza S, Allegra M, Martini A. Ravelli A, et al. Among authors: varnier gc. Arthritis Rheum. 2011 Jan;63(1):267-75. doi: 10.1002/art.30076. Arthritis Rheum. 2011. PMID: 20936630 Free article.
Glucocorticoids in juvenile idiopathic arthritis.
Schiappapietra B, Varnier G, Rosina S, Consolaro A, Martini A, Ravelli A. Schiappapietra B, et al. Neuroimmunomodulation. 2015;22(1-2):112-8. doi: 10.1159/000362732. Epub 2014 Sep 12. Neuroimmunomodulation. 2015. PMID: 25227183 Review.
Advances in biomarkers for paediatric rheumatic diseases.
Consolaro A, Varnier GC, Martini A, Ravelli A. Consolaro A, et al. Among authors: varnier gc. Nat Rev Rheumatol. 2015 May;11(5):265-75. doi: 10.1038/nrrheum.2014.208. Epub 2014 Dec 16. Nat Rev Rheumatol. 2015. PMID: 25512012 Review.
Development and Testing of a Hybrid Measure of Muscle Strength in Juvenile Dermatomyositis for Use in Routine Care.
Varnier GC, Rosina S, Ferrari C, Pistorio A, Consolaro A, Bovis F, Dalprà S, Pilkington C, Maillard S, Civino A, Tsitsami E, de Inocencio J, Jelusic M, Vojinovic J, Espada G, Makay B, Katsicas MM, Pratsidou-Gertsi P, Lazarevic D, Rao AP, Marafon DP, Ruperto N, Martini A, Ravelli A. Varnier GC, et al. Arthritis Care Res (Hoboken). 2018 Sep;70(9):1312-1319. doi: 10.1002/acr.23491. Epub 2018 Aug 12. Arthritis Care Res (Hoboken). 2018. PMID: 29245175
Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis.
Rosina S, Consolaro A, van Dijkhuizen P, Pistorio A, Varnier GC, Bovis F, Nistala K, Maillard S, Civino A, Tsitsami E, de Inocencio J, Jelusic M, Vojinovic J, Espada G, Makay B, Katsicas MM, Pratsidou-Gertsi P, Lazarevic D, Rao AP, Pires Marafon D, Martini A, Pilkington C, Ruperto N, Ravelli A. Rosina S, et al. Among authors: varnier gc. Rheumatology (Oxford). 2019 Jul 1;58(7):1196-1205. doi: 10.1093/rheumatology/key421. Rheumatology (Oxford). 2019. PMID: 30690571
A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis.
Bava C, Mongelli F, Pistorio A, Bertamino M, Bracciolini G, Dalprà S, Davì S, Lanni S, Muratore V, Pederzoli S, Rosina S, Schiappapietra B, Suffia C, Varnier G, Verazza S, Giancane G, Consolaro A, Ravelli A. Bava C, et al. Pediatr Rheumatol Online J. 2019 Jul 25;17(1):50. doi: 10.1186/s12969-019-0355-0. Pediatr Rheumatol Online J. 2019. PMID: 31345226 Free PMC article.
28 results